381
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Endogenous interferon α therapy in follicular lymphoma?

&
Pages 1168-1169 | Published online: 23 Jun 2011

References

  • Swerdlow S, Campo E, Harris N, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.
  • Hiddemann W, Buske C, Dreyling M, Treatment strategies in follicular lymphomas: current status and future perspectives. J Clin Oncol 2005;23:6394–6399.
  • Solal-Céligny P, Roy P, Colombat P, Follicular lymphoma international prognostic index. Blood 2004;104: 1258–1265.
  • Dave S, Wright G, Tan B, Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004;351: 2159–2169.
  • de Jong D, Koster A, Hagenbeek A, Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols. Haematologica 2009;94:70–77.
  • Butsch R, Waeltli S, Schaerer S, Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma. Leuk Lymphoma 2011;52: in press.
  • Pangault C, Amé-Thomas P, Ruminy P, Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH-B-cell axis. Leukemia 2010;24:2080–2089.
  • Siegal F, Kadowaki N, Shodell M, The nature of the principal type 1 interferon-producing cells in human blood. Science 1999;284:1835–1837.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.